The experimental data showed that baicalin treatment in CRC cells increased the protein levels of cell epithelial markers, such as E-cadherin, Cytokeratin 18 and Claudin1, while decreased the protein levels of cell mesenchymal markers, such as N-cadherin and Vimentin (Fig. 6A). The gene discussed is KRT18; the disease is colorectal carcinoma.